Author

Keenan T. Hartert

University of Nebraska Medical CenterORCID 0000-0002-5367-6640Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:whole-exome sequencing· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alyssa C. BouskaiD· 2 shared Dalia Y. MooreiD· 2 shared Jason R. WestiniD· 2 shared Javeed IqbaliD· 2 shared Julie Marie VoseiD· 2 shared Kapil N. BhallaiD· 2 shared Man Chun John MaiD· 2 shared Matthew Alexander LunningiD· 2 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Alyssa C. BouskaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma

Man Chun John Ma, Saber Tadros, Alyssa C. Bouska, Tayla B. Heavican, Haopeng Yang, Qing Deng, Dalia Y. Moore, Ariz Akhter, Keenan T. Hartert, Neeraj Kumar Jain, Jordan Showell, Sreejoyee Ghosh, Lesley E. Street, Marta Beata Davidson, Christopher Daniel Carey, , Michael R. Green

This study identifies subtype-specific and co-occurring genetic alterations across major B-NHL subtypes using targeted sequencing of 380 genes in 685 tumors.

Haematologica · Apr 1, 2021Peer-reviewedGenomics

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in the activated B-cell subtype of diffuse large B-cell lymphoma

Neeraj Kumar Jain, Keenan T. Hartert, Saber Tadros, Warren C. Fiskus, Ondřej Havránek, Man Chun John Ma, Alyssa C. Bouska, Tayla B. Heavican, Dhiraj Kumar, Qing Deng, Dalia Y. Moore, Christine J. Pak, Chih Long Liu, Andrew J. Gentles, Elena Hartmann, , Michael R. Green

The paper identifies TCF4 overexpression driven by 18q21.2 gains as a mechanism promoting IgM expression in ABC-like DLBCL and shows BET inhibitors can suppress it.

Science Translational Medicine · Jun 19, 2019Peer-reviewedGenomics